Absci Corp
ABSI- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001672688
No open-market purchases or sales by Absci Corp insiders were filed in the last 90 days; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.75B in total; ARK Invest is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Absci Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 67 | 114 | +47 |
| Shares | 33.7M | 60.5M | +26.8M (+79.3%) |
| Value | $141.7M | $343.6M | +$201.9M (+142.4%) |
New holders (53)
Institutions that held Absci Corp at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (6)
Institutions that held Absci Corp at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| 683 Capital Management, LLC | 79,780 | $335.1K |
| Balyasny Asset Management LLC | 43,796 | $183.9K |
| Y-Intercept (Hong Kong) Ltd | 20,807 | $87.4K |
| Boothbay Fund Management, LLC | 16,842 | $70.7K |
| Jacobs Levy Equity Management, Inc | 14,042 | $59.0K |
| Cresset Asset Management, LLC | 10,758 | $45.2K |